Inventor

Cornelia Dorner-Ciossek

Inventor
Warthausen, DE

Overview

22→
Patents
2003–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes26%
C07DHeterocyclic compounds26%
C07KPeptides8%
C07CAcyclic or carbocyclic compounds7%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
10,849,907Imidazopyridine derivatives and the use thereof as medicament20209,949,975Inhibitors of beta-secretase20189,526,727'Inhibitors of beta-secretase'20169,211,330'A-beta binding polypeptides'20159,096,603'1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulators'20159,079,905'Compounds for the treatment of CNS disorders'20159,018,391'Inhibitors of beta-secretase'20158,981,112'Inhibitors of β-secretase'20158,664,388'Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture'20148,648,085'1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders'20148,623,879'1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators'20148,623,901'Compounds for the treatment of CNS disorders'20148,614,308'Nucleic acid molecules encoding A-beta binding polypeptides'20138,426,607'Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture'20138,337,845'A-beta binding polypeptides'20128,222,264'Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture'20127,713,961'Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof'20107,534,787'Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds'20097,375,220'Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds'20087,238,774'Statine derivatives for the treatment of Alzheimer\'s disease III'20077,166,599'Trisubstituted pyrimidines'20076,573,276'Muscarinic M1 agonist as an inhibitor of beta-amyloid (A40 and A42)-synthesis'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2018Based in Ingelheim am Rhein, DE· patent location history
2007–2020Patents assigned to BOEHRINGER INGELHEIM INT (16)· patent assignee history
2007–2010Based in Ravensburg, DE· patent location history
2007Based in Goettingen, DE· patent location history
2012–2015Patents assigned to DORNER-CIOSSEK CORNELIA (11)· patent assignee history
2012–2015Patents assigned to FUCHS KLAUS (9)· patent assignee history
2012–2015Patents assigned to HEINE NIKLAS (9)· patent assignee history
2012–2015Patents assigned to EICKMEIER CHRISTIAN (7)· patent assignee history
2012–2020Based in Warthausen, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOEHRINGER INGELHEIM INT162007–2020
DORNER-CIOSSEK CORNELIAself112012–2015
FUCHS KLAUS92012–2015
HEINE NIKLAS92012–2015
EICKMEIER CHRISTIAN72012–2015
Locations
LocationPatentsSpan
Warthausen, DE122012–2020
Ingelheim am Rhein, DE52003–2018
Ravensburg, DE42007–2010
Goettingen, DE12007